Denis Chem Lab Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 339040, "name": "Denis Chem Lab", "stock_name": "Denis Chem Lab", "full_name": "Denis Chem Lab Ltd", "name_url": "stocks-analysis/denis-chem-lab", "exchange": 0, "exchangecode": "", "primexch": 0, "country_id": 34, "currency": "INR", "cmp": "72.94", "chg": 0.94, "chgp": "1.31%", "dir": 1, "prev_price": "72.00", "mcapval": "100.00 Cr", "mcap": "Micro Cap", "scripcode": 537536, "symbol": "", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 40, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE051G01012", "curr_date": "Jun 12, 03:30 PM", "curr_time": "16:35 PM", "last_traded_at": "Jun 12, 03:30 PM IST", "bse_nse_vol": "1.78 k", "exc_status": "Active", "traded_date": "Jun 12, 2026", "traded_date_str": "2026 06 12", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/denis-chem-lab-339040-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Denis Chem Lab Ltd Falls 1.78%: 4 Key Factors Behind the Weekly Decline", "link": "https://www.marketsmojo.com/news/stocks-in-action/denis-chem-lab-ltd-falls-178-4-key-factors-behind-the-weekly-decline-4052999", "imagepath": "", "date": "2026-06-14 12:04:11", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>1 June:</strong> Flat quarterly financial trend reported amid mixed performance</p>\n <p><strong>2 June:</strong> Downgrade to below average quality rating announced</p>\n <p><strong>2 June:</strong> Valuation shifts to very attractive despite market challenges</p>\n <p><strong>5 June:</strong> Week closes at Rs.71.70, down 1.78%</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.73.00</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">R..." }, { "title": "Denis Chem Lab Ltd Valuation Shifts Signal Changing Market Perception", "link": "https://www.marketsmojo.com/news/stocks-in-action/denis-chem-lab-ltd-valuation-shifts-signal-changing-market-perception-4048181", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DenisChemLabLtd_valuationdot_4048181.png", "date": "2026-06-12 08:00:15", "description": "Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift from very attractive to attractive, signalling a nuanced change in price appeal. Despite a challenging return profile relative to the Sensex, the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more favourable entry point for investors, though caution remains warranted given its strong sell mojo grade." }, { "title": "Denis Chem Lab Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/denis-chem-lab-ltd-is-rated-strong-sell-4030705", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DenisChemLabLtd_mojoScore_4030705.png", "date": "2026-06-02 10:10:03", "description": "Denis Chem Lab Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 June 2026, providing investors with the latest perspective on the company’s position." }, { "title": "Denis Chem Lab Ltd Valuation Shifts to Very Attractive Amid Market Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/denis-chem-lab-ltd-valuation-shifts-to-very-attractive-amid-market-challenges-4029146", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DenisChemLabLtd_valuationdot_4029146.png", "date": "2026-06-02 08:01:20", "description": "Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price declines and a challenging market backdrop, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling value compared to peers and historical averages." }, { "title": "Denis Chem Lab Ltd Downgraded to Below Average Quality Amidst Declining Returns and Margins", "link": "https://www.marketsmojo.com/news/stocks-in-action/denis-chem-lab-ltd-downgraded-to-below-average-quality-amidst-declining-returns-and-margins-4028973", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DenisChemLabLtd_qualitydot_4028973.png", "date": "2026-06-02 08:00:19", "description": "Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grading slip from average to below average, prompting a downgrade in its Mojo Grade from Sell to Strong Sell as of 25 Feb 2026. This shift reflects a deterioration in key business fundamentals, including returns on equity and capital employed, as well as concerns over growth consistency and leverage metrics." }, { "title": "Are Denis Chem Lab Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-denis-chem-lab-ltd-latest-results-good-or-bad-4027971", "imagepath": "", "date": "2026-06-01 19:22:03", "description": "Denis Chem Lab Ltd's latest financial results for Q4 FY26 reveal significant operational challenges despite a modest increase in revenue. The company reported net sales of ₹46.75 crores, reflecting a 2.70% growth compared to the previous quarter. However, this revenue growth contrasts sharply with a substantial decline in net profit, which fell to ₹0.40 crores, marking an 81.70% decrease from the prior quarter. This decline in profitability indicates severe margin compression, as evidenced by the operating margin dropping to 5.43% from 13.22% in the previous quarter.\n\nThe results highlight a troubling divergence between top-line growth and bottom-line performance, suggesting that while the company can generate sales, it struggles to convert these into profit effectively. The operating profit also saw a significant decline, collapsing to ₹2.54 crores from ₹6.02 crores in the prior quarter. Additionally, the ..." }, { "title": "Denis Chem Lab Q4 FY26: Profit Plunge and Margin Erosion Cloud Outlook", "link": "https://www.marketsmojo.com/news/result-analysis/denis-chem-lab-q4-fy26-profit-plunge-and-margin-erosion-cloud-outlook-4026928", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DenisChemLab_quaterlyResult_4026928.png", "date": "2026-06-01 13:06:08", "description": "Denis Chem Lab Limited, a micro-cap pharmaceutical manufacturer specialising in sterile intravenous injectables, reported a concerning fourth quarter for FY26, with net profit plummeting 81.70% quarter-on-quarter to just ₹0.40 crores from ₹3.32 crores in Q3 FY26. Despite modest revenue growth of 2.70% QoQ to ₹46.75 crores, the company's profitability collapsed as operating margins contracted sharply from 13.22% to 5.43%, raising serious questions about cost management and operational efficiency." }, { "title": "Denis Chem Lab Ltd Reports Flat Quarterly Financial Trend Amid Mixed Performance", "link": "https://www.marketsmojo.com/news/stocks-in-action/denis-chem-lab-ltd-reports-flat-quarterly-financial-trend-amid-mixed-performance-4026373", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/DenisChemLabLtd_fintrenddot_4026373.png", "date": "2026-06-01 11:00:32", "description": "Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended March 2026, signalling a notable shift from its previously positive growth trajectory. Despite achieving record quarterly net sales, the company faced significant contraction in profitability metrics, prompting a downgrade in its Mojo Grade from Hold to Sell as of 25 February 2026." }, { "title": "Denis Chem Lab Ltd Valuation Shifts Signal Renewed Price Attractiveness", "link": "https://www.marketsmojo.com/news/stocks-in-action/denis-chem-lab-ltd-valuation-shifts-signal-renewed-price-attractiveness-4012384", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DenisChemLabLtd_valuationdot_4012384.png", "date": "2026-05-26 08:00:43", "description": "Denis Chem Lab Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a recalibration in price attractiveness amid evolving market dynamics. Despite a recent downgrade in its overall Mojo Grade to Sell, the company’s valuation metrics suggest a more compelling entry point compared to its historical and peer benchmarks within the Pharmaceuticals & Biotechnology sector." } ], "total": 400, "sid": "339040", "stock_news_url": "https://www.marketsmojo.com/news/denis-chem-lab-339040" }, "announcements": [ { "caption": "Board Meeting Outcome for Outcome Of Board Meeting - Submission Of Audited Financial Results For The Financial Year Ended On 31St March 2026 & Other Intimations", "datetime": "30-May-2026", "details": "the Board of Directors of the Company in their meeting held today i.e. on 30th May 2026 interalia has: 1. Approved the Standalone Audited Financial Statements of the Company for Quarter and Financial Year ended on 31st March 2026 as recommended by the Audit Committee. 2. Recommended a Final dividend of Rs. 2.50 per Equity Share of Rs.10/- each for the financial year 2025-26 ended on 31st March 2026 subject to approval of shareholders/members at the ensuing Annual General Meeting. 3. Considered and approved the appointment of M/s. Kashyap R. Mehta & Partners Company Secretaries Ahmedabad (FRN: P2025GJ106000) (Peer Review Number: 6827/2025) as the Secretarial Auditors of the Company . 4. Considered and approved the appointment of M/s. Kiran J. Mehta & Co. Cost Accountants Ahmedabad (Firm Registration No. 000025) as Cost Auditors of the Company for the FY 2026-27.", "source": "BSE" }, { "caption": "Corporate Action-Board approves Dividend", "datetime": "30-May-2026", "details": "The Board of Directors in their meeting held today recommended a final dividend of Rs. 2.5/- (@25%) per equity share of Rs. 10/- each for the financial year 2025-26 subject to approval of shareholders in Annual General Meeting.", "source": "BSE" }, { "caption": "Results - Financial Results For 31St March 2026.", "datetime": "30-May-2026", "details": "Audited Financial Results for financial year ended on 31st March 2026 along with Auditors report thereon.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Denis Chem Lab Ltd has declared <strong>15%</strong> dividend, ex-date: 19 Sep 25", "dt": "2025-09-19", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "", "data": [ { "txt": "Denis Chem Lab Ltd has announced <strong>2:11</strong> rights issue, ex-date: 07 Sep 17", "dt": "2017-09-07", "middle_text": "Rights Issue" } ] } ] }

Key Events This Week

1 June: Flat quarterly financial trend reported amid mixed performance

2 June: Downgrade to below average quality rating announced

2 June: Valuation shifts to very attractive despite market challenges

5 June: Week closes at Rs.71.70, down 1.78%

Read full news article

Denis Chem Lab Ltd Valuation Shifts Signal Changing Market Perception

2026-06-12 08:00:15

Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its valuation parameters shift from very attractive to attractive, signalling a nuanced change in price appeal. Despite a challenging return profile relative to the Sensex, the company’s current price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more favourable entry point for investors, though caution remains warranted given its strong sell mojo grade.

Read full news article

Denis Chem Lab Ltd is Rated Strong Sell

2026-06-02 10:10:03

Denis Chem Lab Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 01 June 2026, reflecting a reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed here are current as of 02 June 2026, providing investors with the latest perspective on the company’s position.

Read full news article

Denis Chem Lab Ltd Valuation Shifts to Very Attractive Amid Market Challenges

2026-06-02 08:01:20

Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen a notable shift in its valuation parameters, moving from an attractive to a very attractive rating. Despite recent share price declines and a challenging market backdrop, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios now present compelling value compared to peers and historical averages.

Read full news article

Denis Chem Lab Ltd Downgraded to Below Average Quality Amidst Declining Returns and Margins

2026-06-02 08:00:19

Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has seen its quality grading slip from average to below average, prompting a downgrade in its Mojo Grade from Sell to Strong Sell as of 25 Feb 2026. This shift reflects a deterioration in key business fundamentals, including returns on equity and capital employed, as well as concerns over growth consistency and leverage metrics.

Read full news article

Are Denis Chem Lab Ltd latest results good or bad?

2026-06-01 19:22:03

Denis Chem Lab Ltd's latest financial results for Q4 FY26 reveal significant operational challenges despite a modest increase in revenue. The company reported net sales of ₹46.75 crores, reflecting a 2.70% growth compared to the previous quarter. However, this revenue growth contrasts sharply with a substantial decline in net profit, which fell to ₹0.40 crores, marking an 81.70% decrease from the prior quarter. This decline in profitability indicates severe margin compression, as evidenced by the operating margin dropping to 5.43% from 13.22% in the previous quarter. The results highlight a troubling divergence between top-line growth and bottom-line performance, suggesting that while the company can generate sales, it struggles to convert these into profit effectively. The operating profit also saw a significant decline, collapsing to ₹2.54 crores from ₹6.02 crores in the prior quarter. Additionally, the ...

Read full news article

Denis Chem Lab Q4 FY26: Profit Plunge and Margin Erosion Cloud Outlook

2026-06-01 13:06:08

Denis Chem Lab Limited, a micro-cap pharmaceutical manufacturer specialising in sterile intravenous injectables, reported a concerning fourth quarter for FY26, with net profit plummeting 81.70% quarter-on-quarter to just ₹0.40 crores from ₹3.32 crores in Q3 FY26. Despite modest revenue growth of 2.70% QoQ to ₹46.75 crores, the company's profitability collapsed as operating margins contracted sharply from 13.22% to 5.43%, raising serious questions about cost management and operational efficiency.

Read full news article

Denis Chem Lab Ltd Reports Flat Quarterly Financial Trend Amid Mixed Performance

2026-06-01 11:00:32

Denis Chem Lab Ltd, a micro-cap player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended March 2026, signalling a notable shift from its previously positive growth trajectory. Despite achieving record quarterly net sales, the company faced significant contraction in profitability metrics, prompting a downgrade in its Mojo Grade from Hold to Sell as of 25 February 2026.

Read full news article

Denis Chem Lab Ltd Valuation Shifts Signal Renewed Price Attractiveness

2026-05-26 08:00:43

Denis Chem Lab Ltd has witnessed a notable shift in its valuation parameters, moving from a very attractive to an attractive rating, reflecting a recalibration in price attractiveness amid evolving market dynamics. Despite a recent downgrade in its overall Mojo Grade to Sell, the company’s valuation metrics suggest a more compelling entry point compared to its historical and peer benchmarks within the Pharmaceuticals & Biotechnology sector.

Read full news article